GPHF presents 500th Minilab to the Ghanaian Ministry of Health

GPHF presents 500th Minilab to the Ghanaian Ministry of Health

• Merck has been providing compact laboratories for identifying counterfeit
medicines since 1998
• To date, 21 Minilabs are in use in Ghana

Accra, June 6, 2012 – Today, the Global Pharma Health Fund (GPHF) donated a
compact mobile laboratory for identifying counterfeit medicines to the
Ghanaian Ministry of Health. It was the 500th lab that the GPHF, a
charitable initiative financed by Merck, has provided to public and private
health services in developing countries since 1998. Representing the
Ministry of Health, Dr. Stephen K. Opuni, Chief Executive of the Ghana Food
and Drugs Board, the agency charged with ensuring the quality of drugs in
Ghana, received the Minilab in presence of Sylvester A. Mensah, Chief
Executive of the National Health Insurance Authority, and Ghanaian-born
professional soccer player Gerald Asamoah. The Minilab is worth around
9,400 Ghanaian new cedis (approx. € 4,000).

The complete news release can be downloaded at the following link.

Merck's news releases are available at this address: http://media.merck.de


Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.